Fetal lung cyclic ,AMP phosphodiesterase. cyclic ,AMP, phosphatidyl choline, and incorporation of precursors into phosphatidyl choline were measured in rabbits after maternal administration of hydrocortisone phosphate and aminophylline. Both agents inhibited lung phosphodiesterase activity and augmented cyclic A M P concentrations (Table I ). ,\minophylline administration was associated with a significant increase in lung saturated phosphatidjl choline ( Table 2) . Incorporation of ["Cjcholine and IJHjmethionine was increased b! both aminophylline and h!drocortisone (Table 31 . Speculation Aminophylline, which inhibits cyclic A M P phophodiesterase a s its primary mode of action, has effects similar to hydrocortisone on incorporation of labeled precursors into phosphatidyl choline. Cyclic AMP, therefore, may be a mediator of maturation of lung phosphatidyl choline synthesis and/or secretion in the fetus, and pharmacologic agents which enhance cyclic A M P l e~e l s in the lungs may also enhance synthesis of phosphatidyl choline.
Idiopathic respiratory distress syndrome of the newly born usually occurs in infants uith deficient! ,)f pulmonary surfactant at the alveolus (2, 8, 47) . Many investigative efforts, in consequence. have been directed toward study of maturation of surfactant uhich :ippears to consist of several surface-active lipoproteins (12. 28-30) . The single component of surfactant found in the highest concentration (and the best studied) is a saturated phosphatidql choline. dipalniitoql lecithin. uhich accounts for approuimatcly 50'7 of total lung lipids (18) and approximately 40';; ol'lung surface-active mater~al ( I ? ) . Two de tio1.o biusynthetic pathways for phosphatidyl choline have been identified. T h t choline iniot-110-ration pathuay, pcrihw,al% I, probably accounts for more than 9Of!/r, of n e w 1 synthesired lecithin in all mammalian species, hoth fetal and postnatal, studied to date (16. 17) . Path\t.crj, 11. the phosphatidyl ethanolaniine methylation pathway, has also been confirmed in fetal an!m:!l.; hu! proh:ihl\ accounts for on14 minimal amounts of newly synthesized lecithin (16. 17) . In addition to these de tro1.o pathways, restructuring of the lecithin molecule through the lysolecithin pathway is an important, although less well studied, mechanism by which saturation of the acyl groups occurs ( 1 . 24).
Saturated phosphatidyl cholinc can be isolated from fetal lungs in most species during the last half of gestation, with rapidly increasing concentrations appearing at approximately 9OC? of gestation (16. I X ) . During this period increasing surface forces in the lung can be measured, indicating that surface-active conipounds are present in the alveolar spaces (7, 8) .
The rnechanisrns regulating synthesis of phosphatidyl choline are poorly understood. All of the enzymatic activities necessary for its production by both pathways have been identified in f t a l lungs, however (18) . In addition. phosphatidic acid, the most important intermediate compound in glycerolipid synthesis, can be synthesized in fetal lungs (18) . The rate-limiting step in synthesis of phosphatidyl choline appears to be the final reaction with conversion of CDP-choline to choline, involv~ng choline phosphotransferase activit) (17) . This enryme, in addition, appears to be stinlulated selectively when lung maturation is accelerated by corticosteroids (19) . Accelerated rates of phosphatidyl choline synthesis in response to glucocorticoid administration have now been reported in a number of species including fetal sheep, rabbits. and subhuman and human primates. associated in some studies with increased surface forces (14, 15, 17, 19, 27, 33, 34, 38, 39, 44, 49. 50) . Increasing fetal serum concentrations of cortisol near term and increased amniotic fluid cortisol, associated with advancing gestation and maturation of fetal lungs. indicate that increased output of cortisol by fetal adrenal glands may be one mechanism by which normal vaturntion of pulmonary surfactant occurs (18, 20) . Thyroid hormone adniinistration has likewise been reported to stimulate lung phospbatidyl choline synthesis in fetal rabbits (58) as well as in adult. thyroidectomized rats (47) . In addition, disruption of the thyroid-pituitary-adrenal axes by fetal decapitation results in a delay of pulmonary maturation (5, 6, 1 I ).
Although not studied to date in lungs, plucocorticoids enhance concentrations of cyclic A M P in various tissues bq inhibition of cyclic A M P phosphodiesterase (36. 41, 43, 53) . Thyroid hormones also enhance concentrations of cyclic A M P in target tissues through stimulation of adenylate cyclase (37) . Lung tissue studies of cyclic A M P metabolism have to date focused on responses to catecholamines, histamine, prostaglandin E , , and aminophylline. all of which augment cyclic A M P concentrations (9, 13, 31, 32, 45, 46) . Adenylate cyclase has, in addition, been measured in human and rabbit lung homogenates (3. 42) . In the fetal rabbit, by 21 days of gestation adenylate cyclase activity is high and can be stimulated by epinephrine (3). In fetal rabbit lung slices b) daj. 21 cyclic A M P can be identified and its concentration enhanced by histamine and catecholamines (46) . We undertook the present study to determine whether a relationship could be established between surfactant production and cyclic A M P metabolism in fetal lung tissue.
MAT1 R I A L S A N D M E T H O D S
New Zealand albino rabbits with a single 3-hr mating period were studied in pairs. In 10 pairs, hydrocortisone phosphate, I .95 mg/kg/day, was injected three times daily into the study doe (intramuscularly) on dar.7 2 4 2 6 of gestation, with the control doe receiving equal volumes of saline at the same times. In 7 pairs, aminophylline. 6.25 mg/kg/day divided into two doses. was infused intravenously at a rate of 2.5 mg/min between daj.5 24 and 27 of gestation: control does received intravenous infusions of equal volumes of saline.
On day 26 the does were anesthetired with sodium pentobarbital; using sterile techniques we exposed the uterus through a midline abdominal incision. Eighteen hours after the surgical procedure, the does \rere again anesthetired with sodium pentobarbital and killed with intra\.cnous administration of a wturated solution of KCI. The fetuses were rapidly removed and their tracheas clamped to prevent respiration. They ucre ~nimediately exsanguinated by decapitation. the lungs removed. washed free of excess blood \+ith cold normal saline, and divided into three portions. T w o portions of each lung were immediately placed on Dr! Ice and the third portion placed in a saline bath at 4". Fetal lung tissue was pooled so that approximately equal weights of upper and lo\+er lobes were in each portion. The frozen samples were assayed for cyclic A M P content and cyclic A M P phosphodiesterase activit! as described below. Those suniples uhich u e r e placed in cold saline were Iyophili/ed at 3 0 " and later anal>zed for lipid content a s described below. In order to assess the stabilit) 01' cyclic A M P . some lungs were immediately immersed in liquid nitrogen. A comparison was made of the cyclic A M P content of lungs prepared by the two niethods. At the time of study. hydrocortisone had last been administered 18 hr pre\,iouslg. Aniinoph!lline. which has a shorter duration of actlon. was administered I hr before the study.
Cyclic A M P in lung tissue \\as measured b the niethod of Gilman (22) concentration by weight (using a Cahn electrohalance) and hy phosphorus content according to the niethod of Bartlctt (4). The maximum counting efficiencies of the Nuclear Chicago Isocap 300 scintillation counter for the 3H/1.'C-double label program uere 25% and 5OC7r. respectivel!. Efficient! was determined from thc quench curve derived for this program h! use of an el;tern:il standard. R a u counts per min d*td ~h t~t i n e d for '11 and "C w2rc corrected to disintegrations per min in th15 counting program hq using the observed efficiency values for each sample. The calculated disintegrations per min were then used to determine the level of labeled substrate incorporation into the lipids and were expressed in the tables as picomoles of substrate incorporated into pliosphatid!l choline. The computed specific ncti\.ities represent incorporation in terms of moles of methionine and choline into these phospholipids over the IS-hr interval.
The phosphatidbl choline components \yere subsequentl! converted to their respective fatt! acid methll esters using 0.5 N HC'I in methanol: the reactions were carried out in 5-nil ampoules sealed under nitrogen at 80" for 4 hr. T h e resultant fatty acid niethll esters were then uashed and extracted into heptane for injection into a gas-liquid chromatograph (Perkin-Elnier model 80) fitted uith on cth!lene glycol succinate column. Characterilation and quantifjing of individual fatty acid metliql ester coniponents were pcrl'ormed b! referencing against k n o u n standards obtained froni Applied Science Laboratories. The relative proportion of saturated:total phosphatidyl choline was thereb) computed. Weights and crown-rump lengths were determined frorn randonil! chosen lrtuses in each litter.
Comparisons ol' control ~,.v. study fetal lungs were made for cjclic A M P phosphodiesterasc activity, cyclic A M P content. phospholipid content, saturated phosphatidll choline content, and phosphatidyl choline specific activity using Student's t-test ( 5 5 ) . Lung cyclic A M P phosphodiesterase activities and c!clic A M P concentration are s h o n n in Table I . Aminophylline and h!drocortisone both inhib~ted phosphodiesterase ~~c t~v~t ! to ;I highl! significant degree ( P << 0.001 ): a higher concentration of lung cyclic A M P wits present in the l~t t e r s treated u~t h these pharrnacologic agents ( P --0.001). Responses of c!clic A M P pho\phodie\-terase and cyclic A M P to hbdrocc>rtisone and aniinoph>ll~ne Lrcre euual.
Concentrations vl' li~n: total and saturated phosphntidjl cholinc are shown in Table 7 , e\,,!..:ssed both :IS percentage ol'tot:~l lung lipids and as milligrams per g lung tissuc. Diffcrcncc\ ol' total phosphatidyl c h o l~n e among the three groups were not significant. and saturated phosphatidyl choline in the control and hydrocortisone-treated groups were not different. Lungs from the I~ttcr\ treated with aminophylline, houever. had a higher percentage of saturated phosphatidyl c h o i~n e ( P r 0.01 j. its \\ell a s :in absolute increase of caturated phosphat~d!l choline content ( P . 0.075). than the other groups.
Incorporation of ['Hlmethionine and [14Cjcholinc into saturated phosphatidyl choline is shoun in Table 3 . In all three groups of litters choline incorporation accounted for the niajorit~, ol' newl) 
.025).
A recent report h! Karotkin and his couorkers h;i.; demonstrated that prolonged ( 5 I0 days) administration of phenobarbital is assoc~ated nirh dela! ol' p u l m o n a r maturation ( 2 6 ) . .4lthough we anesthetized our does with pentobarbital during the laparotolny and i t g~~i n just before death, we used a verb lou dose of barbiturate which \la\ i d c n t~c~~i In both o u r control and study groups.
Although n~aternitl administration of glucocorticoid\ has been associated with accelerated pulmonarq maturation in sheep. subhuman primates. and human infants (14, 15, 38. 39) . only direct fetal administration of the agents in rabbits has been associated with this response (33, 44). tiihen large doses oT corrisol, iii 30 m g / k g / d a q . mere injected into pregnant rabbit doe\, there L+as a high Incidence ol' fetal wastage and intrauterine growth retardation (44) . T h e much smaller doses of glucocorticoid reported in this stud! resulted in no fetal demise, and biochemical evidence of accelerated shnthex~s of phosphatidhl choline u a s present.
Hydrocortisone and aminophylline administered to pregnant rabbits in this report had similar effects upon cyclic A M P phosphodiester:~se, lung cyclic A M P concentrations, and accelcration of precursor incorporation into phosphatidll choline. In several reports. lung cyclic A M P r e s p o n s e to catecholamines. histanline and arninophylline have been reported, but no previous correlations with phosphatidyl choline svnthesis have been made. other than a single report that dibut) ryl-cyclic A M P administration to adult rats results in an increased lamellar body synthesis and secretion in alveolar type I 1 cells (56) . In fetal rahbits lung cyclic A M P is responsive to catecholamine and histamine stirnulation by 21 daqs of gestation (46) . Adenylate cqclase activity also is high in the s a m e tissue h 21 days and can also be stimulated irr vitro by epinephrine ( 3 ) . Surface propertie\ of fetal rahbit lung. however. develop s o m e a h a t later. and mature pressure-volume relationships a r e normally not obseried until 28 79 days of gestation (33) . This development of mature surface forces is accompanied bq increased production of lung surface-active materials and their increased secretion into the alveolar spaces (27. 33) . Current infornii~tlon indicates that glucocorticoids accelerate lung rnaturatlon b! incre:ts~ng the activit! of choline phosphotranster;~se. the final enrymc in the sqnthesis ol' lecithir, bq the choline ~ncorporation pnthua! (17. 19). T h e effect of g1ucocort1-coids upon secretion into alveoliir spaces ix not k n o u n . Because glucocorticoids evert some metabolic effccts in other tissues through inhibition of cyclic A M P phosphodiesterase and consequent increase of tissue cqclic A M P concentrations ( 3 6 , 4 l , 43) . we tiloushi it pussibli that cjclic A M P rnicht in p-rt rnedi:!!c accelerated surfactant development observed in fetu\es treated with glucocorticoids. We have shown that aminophylline. : I pharmacologic agent with one major mode of action. inhibition of phosphodiesterase, produced responses in fetal lungs that were almost identical to those of glucocorticoids, both with respect to phosphodiesterase and cqclic A M P , and also with respect to increased incorporation of I;tbeled precursors into phosphatidJl choline. We demonstrated the s a m e dramatic increase In incorporation of choline u h~c h has previousl) been reported. In addition. we observed a definite increase in incorporation of methioninc. which is In contrast t o previous reports of Farrell and Zachnian (19) . who noted no response o f p a t h w a y [ I , and Russell et 01. (50) . who reported a decreased incorporation of niethionine into lecith~n in fetuses receiving glucocorticoids. T h e dil'ferences a m o n g these results cannot be explained, but physiologically they are of minor B A R R E T importance since the phosphntidyl ethanolamine methylation pathway contributes little to the total pool of phosphatidql choline. O u r data did not show a significant increase of lung phosphatidyl choline in the cortisone-treated litters, in contrast to the findings of Farrell and Zachman (19) . although increased saturated phosphatidy1 choline was present in the aminophylline-treated litters. It is possible that. by reporting phosphatidyl choline concentration per mg lung wet weight, we are masking changes which are present but of lesser magnitude than changes of lung water content which occur with cortisone administration. In addition, our methodology for determining saturated phosphatidyl choline using gas-liquid chromatography may give values different from the less specific method of acetone precipitation. Finally, the trend toward increased phosphatidyl choline in the hydrocortisone group was present and with a larger number of trials might be significantly different from controls. Our results indicate that aminophylline and glucocorticoids may accelerate lung maturation through a common pathway, inhibition of phosphodiesterase and augmentation of lung cyclic A M P .
Since Liggins and Howie (39) reported decreased morbidity from respiratory distress syndrome and improved survival of infants delivered preterm whose mothers had received high dose @-methasone treatment for 24 hr or more before delivery, this approach has been advocated by some as a means of decreasing the incidence of respiratory distress syndrome. Potential toxicity of maternal corticosteroid administration exists. Mothers with eclampsia treated with @-methasone may have an increased fetal mortality when compared with control mothers (39) . Animal studies indicate that corticosteroids may compromise placental function to the detriment of the fetus (57) and, in addition, inhibit lung growth. although thiseffect is reversible with age ( l o , 35). The reduction in cell number in the brain accompanying glucocorticoid administration to the newborn rodent, however. does not appear to be reversible (25) , and may be accompanied by disturbances of myelination, synaptic growth, and locomotor ability (54) . Moreover, Gross et at. (23) , have shown that corticosteroid administration to fetal rabbits inhibits fatty acid synthetase and acetyl-CoA carboxylase activity in the lung. These animal studies are not comparable with antenatal human administration of glucocorticoids, either in duration or dose of the agents used. They do suggest, however, that antenatal administration of corticosteroids may be accompanied by deleterious effects and point up the need for searching for alternative means for prevention of neonatal respiratory distress syndrome. Our observations suggest that aminophylline or other agents which augment tissue cyclic A M P should be studied for potential effectiveness in the prevention of respiratory distress syndrome.
S U M M A R Y
Since aminophylline and hydrocortisone have similar effects upon lung cyclic A M P phosphodiesterase, cyclic A M P , and incorporation of choline and methionine into phosphatidyl choline in fetal rabbits, it appears that cyclic A M P mediates fetal lung surtactant synthesis. Because maternal administration of glucocorticoids to accelerate lung maturation is not without risk, it seems reasonable to look for other agents, with less risk, that may be equally effective in accelerating maturation of fetal lungs. Aminophylline or other agents which inhibit cyclic A M P phosphodiesterase activity should be studied, but because of widespread effect of cyclic A M P , may present the same risk to the fetus as glucocorticoids. 
Aspartylglucosaminuria

Extract
The activity of the glycoprotein degrading lysosomal hydrolase, 4-L-aspartylglycosylamine amido hydrolase (AADGase, EC.3.5.1.26), was measured in plasma, buffy coat leukocytes, and separated lymphocytes (Ficoll separation) from 16 patients with aspartylglucosaminuria (AGU), 29 obligate heterozygotes, and 30 control subjects. In lymphocytes the AGU patients had unmeasurable or minimal AADGase activity with a mean of 3.9 U. The obligate heterozygotes showed AADGase activities ranging from 5 to 69 U with a mean of 34.1 U. Enzyme activities in the control group ranged from 91 to 243 U with a mean of 127.9 U. and were clearly separated from the values of the heterozygotes.
In leukocytes the AGU patients had unmeasurable enzyme activity and obligate heterozygotes had enzyme levels closely similar to those in the lymphocytes from the same individuals. The AADGase activity in the leukocytes of the control group displayed a much wider rariatioi; :hai; ia :hc lymp.h.ocy$es, ranging from 22 !n 132 LJ with a mean of 70.7 U.
In plasma the AGU patients had undetectable AADGase actitity. The mean enzyme letel of obligate heterozygotes was 72.2 U and that of control individuals 107.2 U, but the overlap between the groups was extensive. The results indicate that homozygous deficiency of AADGase, i.e., aspartylglucosaminuria, can be reliably diagnosed using plasma, leukocytes, or separated lymphocytes. For carrier detection only separated lymphocytes allow a satisfactory differentiation between heterozygous and normal individuals.
A group of 31 siblings of verified AGU cases and 11 children of identified carriers, whose spouses had normal AADGase activity, were investigated using the lymphocyte assay. The observed and expected frequencies (on the basis of Mendelian probabilities) were closely similar, suggesting that the lymphocyte assay can be used reliably for carrier detection.
